Cargando…
Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the intera...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898482/ https://www.ncbi.nlm.nih.gov/pubmed/33090600 http://dx.doi.org/10.1002/chem.202004076 |
_version_ | 1783653868519817216 |
---|---|
author | Doelman, Ward Marqvorsen, Mikkel H. S. Chiodo, Fabrizio Bruijns, Sven C. M. van der Marel, Gijsbert A. van Kooyk, Yvette van Kasteren, Sander I. Araman, Can |
author_facet | Doelman, Ward Marqvorsen, Mikkel H. S. Chiodo, Fabrizio Bruijns, Sven C. M. van der Marel, Gijsbert A. van Kooyk, Yvette van Kasteren, Sander I. Araman, Can |
author_sort | Doelman, Ward |
collection | PubMed |
description | The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the interaction of Lewis‐type glycan structures in the N‐glycan of MOG with the DC‐SIGN receptor on dendritic cells (DCs). Here, we report the synthesis of an unnatural Lewis X (Le(X))‐containing Fmoc‐SPPS‐compatible asparagine building block (SPPS=solid‐phase peptide synthesis), as well as asparagine building blocks containing two Le(X)‐derived oligosaccharides: LacNAc and Fucα1‐3GlcNAc. These building blocks were used for the glycosylation of the immunodominant portion of MOG (MOG(31‐55)) and analyzed with respect to their ability to bind to DC‐SIGN in different biological setups, as well as their ability to inhibit the citrullination‐induced aggregation of MOG(31‐55). Finally, a cytokine secretion assay was carried out on human monocyte‐derived DCs, which showed the ability of the neoglycopeptide decorated with a single Le(X) to alter the balance of pro‐ and anti‐inflammatory cytokines, inducing a tolerogenic response. |
format | Online Article Text |
id | pubmed-7898482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78984822021-03-03 Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis Doelman, Ward Marqvorsen, Mikkel H. S. Chiodo, Fabrizio Bruijns, Sven C. M. van der Marel, Gijsbert A. van Kooyk, Yvette van Kasteren, Sander I. Araman, Can Chemistry Full Papers The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the interaction of Lewis‐type glycan structures in the N‐glycan of MOG with the DC‐SIGN receptor on dendritic cells (DCs). Here, we report the synthesis of an unnatural Lewis X (Le(X))‐containing Fmoc‐SPPS‐compatible asparagine building block (SPPS=solid‐phase peptide synthesis), as well as asparagine building blocks containing two Le(X)‐derived oligosaccharides: LacNAc and Fucα1‐3GlcNAc. These building blocks were used for the glycosylation of the immunodominant portion of MOG (MOG(31‐55)) and analyzed with respect to their ability to bind to DC‐SIGN in different biological setups, as well as their ability to inhibit the citrullination‐induced aggregation of MOG(31‐55). Finally, a cytokine secretion assay was carried out on human monocyte‐derived DCs, which showed the ability of the neoglycopeptide decorated with a single Le(X) to alter the balance of pro‐ and anti‐inflammatory cytokines, inducing a tolerogenic response. John Wiley and Sons Inc. 2020-12-28 2021-02-05 /pmc/articles/PMC7898482/ /pubmed/33090600 http://dx.doi.org/10.1002/chem.202004076 Text en © 2020 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Full Papers Doelman, Ward Marqvorsen, Mikkel H. S. Chiodo, Fabrizio Bruijns, Sven C. M. van der Marel, Gijsbert A. van Kooyk, Yvette van Kasteren, Sander I. Araman, Can Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title | Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title_full | Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title_fullStr | Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title_full_unstemmed | Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title_short | Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis |
title_sort | synthesis of asparagine derivatives harboring a lewis x type dc‐sign ligand and evaluation of their impact on immunomodulation in multiple sclerosis |
topic | Full Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898482/ https://www.ncbi.nlm.nih.gov/pubmed/33090600 http://dx.doi.org/10.1002/chem.202004076 |
work_keys_str_mv | AT doelmanward synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT marqvorsenmikkelhs synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT chiodofabrizio synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT bruijnssvencm synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT vandermarelgijsberta synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT vankooykyvette synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT vankasterensanderi synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis AT aramancan synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis |